Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Clinical Trial, Phase I

Multicenter Study

Clinical Trial, Phase II

Review

Comparative Study

Research Support, U.S. Gov't, P.H.S.

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2026

2024

2017

2015

2013

2012

2005

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Staphylococcal Vaccines""[mesh_terms]

13 Results

Searching titles within these results

Progress toward a Staphylococcus aureus vaccine.

Brad Spellberg, Robert S Daum

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(4):560-7

Free Full Text

Abstract

Staphylococci in colonization and disease: prospective targets for drugs and vaccines.

Friedrich Götz

Current opinion in microbiology 2005;7(5):477-87

Full Text

Abstract

AntiPan: a genome-informed in silico pipeline for advancing subunit vaccine discovery against Staphylococcus aureus.

Mostafa S Ibrahim, Jala A Fahmy, Mohamed A Helal, Fady T Hakim, Lydia R Sidarous, Nayera E Attallah, Sherif Abouelhadid, Mohamed Elhadidy, Eman Badr

Scientific reports 2026;16(1):5396

Free Full Text

Abstract

Immunoinformatic approach for multi-epitope vaccine design against Staphylococcus aureus based on hemolysin proteins.

Fatima Shahid, Maaz Waseem, Lennin Isaac Garrido-Palazuelos, Arath Andrés Almanza-Orduño, Amina Basheer, José Andrés Medrano-Félix, Mamuna Mukthar, Haris Ahmed-Khan, José Roberto Aguirre-Sánchez

Journal of molecular graphics & modelling 2024;132():108848

Full Text

Abstract

New possibilities of prevention of infection in the newborn.

Mauro Stronati, Chryssoula Tzialla, Paolo Manzoni, Lidia Decembrino, Alessandro Borghesi

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2012;24 Suppl 2():28-30

Full Text

Abstract

Computational and immunoinformatics approaches for designing phytocompound-based drugs and a multi-epitope vaccine targeting FemA, a cell wall protein of Staphylococcus aureus.

Md Nazmussakib Shuvo, Tawsif Al Arian, Farhan Fuad, Mahmood Hasan Noman, Nuhu Alam, Mahbubul Kabir Himel, Aparna Shil

PloS one 2026;21(4):e0346271

Full Text

Abstract

Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.

Moustafa Moustafa, George R Aronoff, Chandra Chandran, Jonathan S Hartzel, Steven S Smugar, Claude M Galphin, Lionel U Mailloux, Elizabeth Brown, Mark J Dinubile, Nicholas A Kartsonis, Dalya Guris

Clinical and vaccine immunology : CVI 2013;19(9):1509-16

Free Full Text

Abstract

The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): results of two Phase I studies.

Clayton D Harro, Robert F Betts, Jonathan S Hartzel, Matthew T Onorato, Joy Lipka, Steven S Smugar, Nicholas A Kartsonis

Vaccine 2012;30(9):1729-36

Full Text

Abstract

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

Vance G Fowler, Keith B Allen, Edson D Moreira, Moustafa Moustafa, Frank Isgro, Helen W Boucher, G Ralph Corey, Yehuda Carmeli, Robert Betts, Jonathan S Hartzel, Ivan S F Chan, Tessie B McNeely, Nicholas A Kartsonis, Dalya Guris, Matthew T Onorato, Steven S Smugar, Mark J DiNubile, Ajoke Sobanjo-ter Meulen

JAMA 2013;309(13):1368-78

Full Text

Abstract

SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.

Elizabeth Begier, David Joshua Seiden, Michael Patton, Edward Zito, Joseph Severs, David Cooper, Joseph Eiden, William C Gruber, Kathrin U Jansen, Annaliesa S Anderson, Alejandra Gurtman

Vaccine 2017;35(8):1132-1139

Full Text

Abstract

Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.

Jack Levy, Laurent Licini, Edwige Haelterman, Philippe Moris, Pascal Lestrate, Silvia Damaso, Pascale Van Belle, Dominique Boutriau

Human vaccines & immunotherapeutics 2015;11(3):620-31

Free Full Text

Abstract

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.

Robert W Frenck, C Buddy Creech, Eric A Sheldon, David J Seiden, Martin K Kankam, James Baber, Edward Zito, Robin Hubler, Joseph Eiden, Joseph M Severs, Shite Sebastian, Jasdeep Nanra, Kathrin U Jansen, William C Gruber, Annaliesa S Anderson, Douglas Girgenti

Vaccine 2017;35(2):375-384

Free Full Text

Abstract

Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.

Eric A Sheldon, David J Seiden, Martin K Kankam, James Baber, C Buddy Creech, Robert W Frenck, Edward T Zito, Douglas Girgenti, Joseph M Severs, Frederick W Immermann, Lisa K McNeil, David Cooper, Kathrin U Jansen, William Gruber, Joseph Eiden, Annaliesa S Anderson

Vaccine 2017;35(2):385-394

Free Full Text

Abstract

Results: 1 – 13 / 13

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Staphylococcal Vaccines""[mesh_terms]

Progress toward a Staphylococcus aureus vaccine.

Staphylococci in colonization and disease: prospective targets for drugs and vaccines.

AntiPan: a genome-informed in silico pipeline for advancing subunit vaccine discovery against Staphylococcus aureus.

Immunoinformatic approach for multi-epitope vaccine design against Staphylococcus aureus based on hemolysin proteins.

New possibilities of prevention of infection in the newborn.

Computational and immunoinformatics approaches for designing phytocompound-based drugs and a multi-epitope vaccine targeting FemA, a cell wall protein of Staphylococcus aureus.

Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.

The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): results of two Phase I studies.

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.

Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.

Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.

Results for
""Staphylococcal Vaccines""[mesh_terms]